1. Home
  2. GTLS vs CYTK Comparison

GTLS vs CYTK Comparison

Compare GTLS & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Chart Industries Inc.

GTLS

Chart Industries Inc.

HOLD

Current Price

$207.31

Market Cap

9.3B

Sector

Industrials

ML Signal

HOLD

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$63.37

Market Cap

8.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GTLS
CYTK
Founded
1859
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.3B
8.0B
IPO Year
1992
2004

Fundamental Metrics

Financial Performance
Metric
GTLS
CYTK
Price
$207.31
$63.37
Analyst Decision
Buy
Strong Buy
Analyst Count
12
16
Target Price
$205.40
$82.38
AVG Volume (30 Days)
534.9K
2.2M
Earning Date
02-27-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.86
N/A
Revenue
$4,291,200,000.00
$87,211,000.00
Revenue This Year
$8.38
$339.72
Revenue Next Year
$11.36
$79.08
P/E Ratio
$240.36
N/A
Revenue Growth
5.47
2609.26
52 Week Low
$104.60
$29.31
52 Week High
$220.03
$70.98

Technical Indicators

Market Signals
Indicator
GTLS
CYTK
Relative Strength Index (RSI) 71.73 50.00
Support Level $206.63 $60.30
Resistance Level $206.96 $65.35
Average True Range (ATR) 0.36 3.01
MACD -0.03 -0.01
Stochastic Oscillator 76.13 57.11

Price Performance

Historical Comparison
GTLS
CYTK

About GTLS Chart Industries Inc.

Chart Industries provides a variety of cryogenic equipment for storage, distribution, and other processes within the industrial gas and liquefied natural gas industries. It also provides natural gas processing solutions for the natural gas industry and specialty products that serve a variety of spaces, including hydrogen, biofuels, cannabis, and water treatment. The firm acquired Howden in a significant deal in early 2023, roughly doubling the size of the company. It plans to merge with Flowserve by the end of 2025.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: